Chaves E, Jeffrey DT, Williams DR
Joshi, MBBS, MD, FASA, October 22, 2025 GLP-1 Agonist Medications for Diabetes or Weight Loss Certain types of medications taken for weight loss or diabetes management can affect the safety of patients when they undergo general anesthesia or deep sedation
Regulatory agencies caution against using diluents without preservatives, as this can result in peptide degradation and precipitation
Abstract In healthy humans, the incretin glucagon-like peptide 1 (GLP-1) is secreted after eating and lowers glucose concentrations by augmenting insulin secretion and suppressing glucagon release
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
You receive guidance on movement and exercise to enhance metabolic rate and muscle mass